SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?


To: Marshall Teitelbaum who wrote (2178)10/4/2001 3:34:19 PM
From: rairden  Respond to of 2205
 
No ATIS angle on burn victims?
There weren't as many burn patients
as originally expected, but several are
still in critical condition at Cornell's
Weill Medical College Burn Center,
having undergone extensive skin grafts.
Sounds like all the replacement skin
came from cadavers.
No mention of TransCyte® anywhere.



To: Marshall Teitelbaum who wrote (2178)10/4/2001 7:28:31 PM
From: Gary Stern  Read Replies (1) | Respond to of 2205
 
Your post makes some good points. I'm long for 5 years with a good sized position. While I would hate to miss the one great winner of my life, at some point, with a 3.5 ave. cost I would be compelled to sell. Have you formulated exit points or are you just in the hold and see mindset.

I keep thinking that if I sold ATIS every time it hit 6 and I bought every time it fell to 3.5 I would be a very rich man given the size of my current investment. I think one can have faith in the company and still be prepared to sell and wait for a reentry point. On the day it spiked to 15 when the cardio patch was announced I was out of the office and my sell orders missed the falling price. I wanted to be out at 12 that day; which would have allowed me to buy back in a few months with a position almost 4 times my current holding. The thought of owning 50K of this co. today would do a lot for my retirement planning and I wish I had been around to have my prior sell order executed.